Biohaven Pharmaceutical Holding Co Ltd.

CIK 1689813 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Biohaven Pharmaceutical Holding Co Ltd..

Recent SEC filings

FiledFormAccession number
Oct 14, 202215-12G0001193125-22-262529
Oct 5, 202240001562180-22-007082
Oct 4, 202225-NSE0000876661-22-000807
Oct 3, 202240001562180-22-006962
Oct 3, 202240001562180-22-006956
Oct 3, 20228-K0001628280-22-025891
Oct 3, 2022S-8 POS0001628280-22-025882
Oct 3, 202240001562180-22-006959
Oct 3, 202240001562180-22-006955
Oct 3, 202240001562180-22-006953
Oct 3, 202240001562180-22-006957
Oct 3, 2022POSASR0001628280-22-025890
Oct 3, 202240001562180-22-006951
Oct 3, 2022S-8 POS0001628280-22-025888
Oct 3, 202240001562180-22-006954
Oct 3, 2022S-8 POS0001628280-22-025884
Oct 3, 202240001562180-22-006952
Oct 3, 202240001562180-22-006964
Oct 3, 202240001562180-22-006950
Oct 3, 2022S-8 POS0001628280-22-025886
Oct 3, 202240001562180-22-006958
Oct 3, 202240001562180-22-006961
Oct 3, 202240001562180-22-006960
Oct 3, 202240001562180-22-006949
Oct 3, 202240001562180-22-006963